Supernus Pharmaceuticals reported $668.38M in Current Assets for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Assets Change
Adamas Pharmaceuticals ADMS:US 108M 7.65M
Aerie Pharmaceuticals AERI:US $ 275.95M 13.07M
Ani Pharmaceuticals ANIP:US $ 191.38M 415K
Aphria Inc APH:CN C$ 730.7M 38.56M
Aurora Cannabis Inc ACB:CN 653.01M 12.89M
Bristol Myers Squibb BMY:US $ 31443M 2282M
Canopy Growth Corp WEED:CN C$ 2.5B 172.17M
Cara Therapeutics CARA:US $ 171.5M 7.03M
Corcept Therapeutics CORT:US $ 401.9M 9.37M
Eisai 4523:JP Y 570717M 8210M
Eli Lilly And LLY:US $ 17808.3M 512.8M
Endo International Ordinary Shares ENDP:US $ 2748.95M 179.62M
Gw Pharmaceuticals GWPH:US $ 718.73M 10.8M
Horizon Pharma HZNP:US $ 2413.92M 238.54M
JAZZ PHA JAZZ:US $ 2628.23M 325.74M
Lannett LCI:US $ 364.89M 11.33M
Marinus Pharmaceuticals MRNS:US $ 153.49M 32.57M
Pacira Pharmaceuticals PCRX:US $ 822.35M 29.77M
Perrigo Ordinary Shares PRGO:US $ 4225.9M 194.3M
Revance Therapeutics RVNC:US $ 293.88M 60.72M
Supernus Pharmaceuticals SUPN:US $ 668.38M 29.13M
Teva Pharmaceutical Industries TEVA:US $ 12154M 668M
United Therapeutics UTHR:US $ 2385.9M 68M
Xeris Pharmaceuticals Inc XERS:US $ 124.37M 20.22M